AbbVie
ABBV
#26
Rank
HK$2.741 T
Marketcap
HK$1,551
Share price
-0.50%
Change (1 day)
43.32%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of June 2024 : HK$549.19 Billion

According to AbbVie's latest financial reports the company's total debt is HK$549.19 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31HK$463.79 B-6.18%
2022-12-31HK$494.35 B-17.33%
2021-12-31HK$597.94 B-10.37%
2020-12-31HK$667.12 B28.37%
2019-12-31HK$519.68 B64.63%
2018-12-31HK$315.66 B8.12%
2017-12-31HK$291.95 B2.19%
2016-12-31HK$285.69 B16.38%
2015-12-31HK$245.47 B111.31%
2014-12-31HK$116.16 B1.75%
2013-12-31HK$114.16 B-6.02%
2012-12-31HK$121.47 B32484%
2011-12-31HK$0.37 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
HK$533.97 B-2.77%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$399.64 B-27.23%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$241.96 B-55.94%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$469.60 B-14.49%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$181.55 B-66.94%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$51.77 B-90.57%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$167.10 B-69.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$260.72 B-52.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$1.95 B-99.64%๐Ÿ‡บ๐Ÿ‡ธ USA